3 Thoughts From an Autism Researcher on Trump's Acetaminophen and Vaccine Claims | KQED
Briefly

3 Thoughts From an Autism Researcher on Trump's Acetaminophen and Vaccine Claims | KQED
""Don't let them pump your baby up with the largest pile of stuff you've ever seen in your life, going into the delicate little body of a baby, even if it's two years, three years, four years, you just break it up into, I would say five, but let's say four, four visits to the doctor instead of one.""
""likely to raise fear among mothers, confusion and chaos for pediatricians." "This is really not what our society needs right now,""
""We need a study to investigate this right now, far before the FDA ... should be approving this medication," "They haven't done this for a single other medication in the history of autism.""
A proposal urges splitting MMR vaccine doses across multiple pediatric visits to reduce the number of antigens administered at once. Such proposals can increase parental fear, create confusion, and complicate pediatric practice. The FDA labeled leucovorin as a treatment for speech-related deficits associated with autism despite only small-scale, promising evidence. Larger randomized controlled trials are needed to confirm language benefits, determine appropriate dosages, identify which children might benefit, and define expected outcomes before broad clinical approval. Premature adoption of unproven interventions risks diverting families and clinicians from evidence-based care.
Read at Kqed
Unable to calculate read time
[
|
]